Form 4: Insider Buys UTMD Stock

Director Paul O. Richins of Utah Medical Products Inc. acquired 150 shares of common stock on June 29, 2026, at a price of $73.07 per share.

Summary

• Paul O. Richins, a Director at Utah Medical Products Inc. (UTMD), reported a transaction on June 29, 2026.
• Richins acquired 150 shares of common stock at a price of $73.07 per share.
• Following this transaction, Richins beneficially owns 20,765 shares.
• These shares are held indirectly through various entities including his spouse's IRA (1,245 shares), his son (222 shares), his own IRA (500 shares), and the Richins Family Trust (18,798 shares).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents a director's investment in the company, which can signal confidence, but it is a routine disclosure without broader financial performance data.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The purchase price of $73.07 per share indicates a belief that the current market valuation is attractive.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider purchases, particularly by directors, are often viewed positively by the market as they can indicate management's belief in the company's intrinsic value and future growth potential. This transaction by a director of Utah Medical Products Inc. aligns with this general market sentiment.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive signal of management's confidence in the company's stock value.

Key Dates

Keywords

UTMD, Utah Medical Products Inc., Form 4, Insider Trading, Director Transaction, Common Stock, Beneficial Ownership